Nature Communications (Jan 2022)

Robust and durable serological response following pediatric SARS-CoV-2 infection

  • Hanna Renk,
  • Alex Dulovic,
  • Alina Seidel,
  • Matthias Becker,
  • Dorit Fabricius,
  • Maria Zernickel,
  • Daniel Junker,
  • Rüdiger Groß,
  • Janis Müller,
  • Alexander Hilger,
  • Sebastian F. N. Bode,
  • Linus Fritsch,
  • Pauline Frieh,
  • Anneke Haddad,
  • Tessa Görne,
  • Jonathan Remppis,
  • Tina Ganzemueller,
  • Andrea Dietz,
  • Daniela Huzly,
  • Hartmut Hengel,
  • Klaus Kaier,
  • Susanne Weber,
  • Eva-Maria Jacobsen,
  • Philipp D. Kaiser,
  • Bjoern Traenkle,
  • Ulrich Rothbauer,
  • Maximilian Stich,
  • Burkhard Tönshoff,
  • Georg F. Hoffmann,
  • Barbara Müller,
  • Carolin Ludwig,
  • Bernd Jahrsdörfer,
  • Hubert Schrezenmeier,
  • Andreas Peter,
  • Sebastian Hörber,
  • Thomas Iftner,
  • Jan Münch,
  • Thomas Stamminger,
  • Hans-Jürgen Groß,
  • Martin Wolkewitz,
  • Corinna Engel,
  • Weimin Liu,
  • Marta Rizzi,
  • Beatrice H. Hahn,
  • Philipp Henneke,
  • Axel R. Franz,
  • Klaus-Michael Debatin,
  • Nicole Schneiderhan-Marra,
  • Ales Janda,
  • Roland Elling

DOI
https://doi.org/10.1038/s41467-021-27595-9
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 11

Abstract

Read online

In this prospective cohort study, authors follow 328 households in Germany with at least one confirmed SARS-CoV-2 infection and find that children are more likely to seroconvert without symptoms and have higher specific antibody levels that persist longer than in adults.